US Patent Issued to Incyte Holdings, Incyte on Sept. 30 for "Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b[1,2,4triazin-2-ylbenzamide and processes related to preparing the same" (Pennsylvania, Delaware Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,154, issued on Sept. 30, was assigned to Incyte Holdings Corp. (Wilmington, Del.) and Incyte Corp. (Wilmington, Del.).

"Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b[1,2,4triazin-2-ylbenzamide and processes related to preparing the same" was invented by Lingkai Weng (Malvern, Pa.), Lei Qiao (Downingtown, Pa.), Jiacheng Zhou (Newark, Del.), Pingli Liu (Newark, Del.) and Yongchun Pan (Newark, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to dihydrochloric acid and dibenzenesulfonic acid salts of the c-Met kinase inhibitor 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)-imidazo[1,2-b][1,2,4]t...